Kazald1 - Kazal-type serine peptidase inhibitor domain 1

Predicted to enable insulin-like growth factor binding activity. Predicted to be involved in regulation of signal transduction. Predicted to act upstream of or within extracellular matrix organization. Predicted to be located in extracellular matrix. Predicted to be active in interstitial matrix. Orthologous to human KAZALD1 (Kazal type serine peptidase inhibitor domain 1). [provided by Alliance of Genome Resources, Apr 2022]